These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8503120)

  • 21. Coagulation activation in extracorporeal hemodialysis.
    Camici M; Evangelisti L; Balestri P; Cioni L; Rindi P; Sagripanti A; Meriggioli M; Giordani R
    Int J Artif Organs; 1997 Mar; 20(3):163-5. PubMed ID: 9151152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low levels of coagulation inhibitors in patients with Clostridium difficile infection.
    Aronsson B; Blombäck M; Eriksson S; Egberg N
    Infection; 1992; 20(2):58-60. PubMed ID: 1533851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cerebral infarctions in young patients related to deficiency of natural anticoagulants. Protein C and protein S].
    Siqueira Neto JI; Santos AC; Fábio SR; Sakamoto AC
    Arq Neuropsiquiatr; 1996 Dec; 54(4):590-4. PubMed ID: 9201339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Deficiencies of physiological coagulation inhibitors in children with venous thromboses of the lower limbs. Prospective study of 6 cases].
    Khaldi F; Toumi NH; Ben Jaballah N; Zriba S; Ben Naceur B
    Ann Pediatr (Paris); 1993 Jun; 40(6):348-52. PubMed ID: 8352495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Coagulation factor VII levels in uremic patients and theirs influence factors].
    Fang J; Xia LH; Wei WN; Song SJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):730-2. PubMed ID: 15631649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma anticoagulant system in patients with pulmonary hypertension.
    Maeda NY; Lopes AA; da-Rocha TR; Chamone DA
    Braz J Med Biol Res; 1990; 23(3-4):251-4. PubMed ID: 2151253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low levels of the anticoagulant activity of protein C in patients with chronic renal insufficiency: an inhibitor of protein C is present in uremic plasma.
    Faioni EM; Franchi F; Krachmalnicoff A; Valsecchi C; Viganò GL; Remuzzi G; Mannucci PM
    Thromb Haemost; 1991 Oct; 66(4):420-5. PubMed ID: 1796390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effects of erythropoietin treatment on the coagulation system during standardized hemodialysis.
    Clyne N; Lins LE; Egberg N
    Clin Nephrol; 1995 Apr; 43(4):260-7. PubMed ID: 7606881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
    Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of fibrinolytic activity of uremic and longterm hemodialytic patients with special reference to fibrinolytic inhibitor.
    Homma T; Ichikawa T
    Biochem Exp Biol; 1979; 15(3):229-36. PubMed ID: 122165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of recombinant human erythropoietin on physiological inhibitors of coagulation in children on continuous ambulatory peritoneal dialysis.
    Kisaarslan FA; Gündüz Z; Düsünsel R; Poyrazoglu HM; Saraymen R; Elmas B
    Adv Perit Dial; 1999; 15():273-7. PubMed ID: 10682117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variations in hematocrit induced by hemodialysis.
    Di Iorio B; Bellizzi V
    Blood Purif; 2001; 19(1):68-9. PubMed ID: 11114580
    [No Abstract]   [Full Text] [Related]  

  • 33. Protein C abnormalities in spinal cord injured patients with end-stage renal disease.
    Vaziri ND; Patel B; Gonzales AE; Winer RL; Eltorai I; Gordon S; Danviryasup K
    Arch Phys Med Rehabil; 1987 Nov; 68(11):791-3. PubMed ID: 3675178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Protein C, protein S and antithrombin III at normal delivery and during abruptio placentae].
    Thiam D; Diop S; Ba Gueye M; Fall K; Toure AO; Diadhiou F; Diakhate L
    Dakar Med; 1999; 44(1):54-7. PubMed ID: 10797988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antithrombin III in chronic renal insufficiency].
    Bekić-Kaluza S; Macanović M
    Med Arh; 1991; 45(1-2):3-8. PubMed ID: 1366314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of desmopressin on protein S and antithrombin III in uremia.
    Akpolat T; Eser M; Albayrak D; Arik N
    Nephron; 1997; 77(3):362. PubMed ID: 9375836
    [No Abstract]   [Full Text] [Related]  

  • 37. Laboratory identification of conditions predisposing to thrombosis.
    Sanfelippo MJ; Caya JG
    Wis Med J; 1990 Nov; 89(11):635-8. PubMed ID: 2148045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient removal of albumin-bound furancarboxylic acid by protein-leaking hemodialysis.
    Niwa T; Asada H; Tsutsui S; Miyazaki T
    Am J Nephrol; 1995; 15(6):463-7. PubMed ID: 8546166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein C deficiency and stroke in early life.
    Kennedy CR; Warner G; Kai M; Chisholm M
    Dev Med Child Neurol; 1995 Aug; 37(8):723-30. PubMed ID: 7672469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between plasma phosphate concentration and hematocrit in uremic patients undergoing hemodialysis.
    Gonella M
    Nephron; 1980; 26(2):100. PubMed ID: 7412960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.